This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Gary Held
Staff Scientist, Analytical Development at Thermo Fisher Scientific


Gary Held, MBA Staff Scientist, Analytical Development Thermo Fisher Scientific Gary Held has been working in the Phosphoramidite and Nucleotide space at Thermo Fisher for almost 20 years. His expertise is in product testing and impurity identification using a number of techniques including LCMS and NMR. He has published several articles and application notes related to impurity formation and control in the amidite supply change and chemical synthesis. Prior experience includes leading analytical development and quality control teams for small molecule API manufacturers.

Agenda Sessions

  • Impurity Analysis of Phosphoramidites for Manufacturing Oligonucleotide Therapeutics